Michal Cohen-Naftaly

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
BACKGROUND & AIMS Hepatocellular Carcinoma (HCC) is the sixth most common malignancy and the third most common cause of cancer mortality worldwide. We aimed to assess the effect of novel treatment options on the survival of HCC patients. METHODS This retrospective study included all HCC patients diagnosed between 2000 and 2013 referred to the Davidoff(More)
  • 1